Renal impairment: In patients with existing kidney disease, dehydration from gastrointestinal effects can worsen renal function
10.1016/j.jclinane.2024.111668 [DOI] [PubMed] [Google Scholar] 24.Kobori T, Onishi Y, Yoshida Y, Tahara T, Kikuchi T, Kubota T et al (2023) Association of glucagon-like peptide-1 receptor agonist treatment with gastric residue in an esophagogastroduodenoscopy
Until now, Wegovy was only available as a once-weekly injection
What the 1mg dose delivers: Maximum HbA1c reduction the strongest blood sugar control semaglutide offers at this tier Sustained, significant weight loss clinical trials show continued loss well beyond initial months Robust cardiovascular protection significantly reduced risk of major cardiac events Chronic kidney disease risk reduction meaningful renal protection for long-term health Full appetite regulation hunger is consistently managed, making healthy choices easier Same once-weekly pre-filled syringe no change in routine, just stronger results Who is it for
While short-term studies show promising results in weight loss and belly fat reduction, the sustainability of these results over the long term is yet to be fully understood
Baseline labs are required and arranged through partner labs